Cancer Research Targets  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 5999-6004, December 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fridman, J. S.
Right arrow Articles by Maybaum, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fridman, J. S.
Right arrow Articles by Maybaum, J.
[Cancer Research 59, 5999-6004, December 1, 1999]
© 1999 American Association for Cancer Research


Tumor Biology

bcl-Xs-induced Cell Death in 3T3 Cells Does Not Require or Induce Caspase Activation1

Jordan S. Fridman, Mary A. Benedict and Jonathan Maybaum2

Departments of Pharmacology [J. S. F., J. M.] and Pathology [M. A. B.], University of Michigan Medical School, Ann Arbor, Michigan 48109

Using a tetracycline-regulated expression system, we have shown that expression of bcl-XS is sufficient to induce acute cell death in 3T3 cells, and that the manner in which these cells die is both morphologically and biochemically different from Fas/CD95-induced apoptosis. bcl-XS expression causes loss of the inner mitochondrial membrane potential ({Delta}{Psi}m) but does not induce caspase activation. Loss of viability, as determined by mitochondrial function and ethidium bromide exclusion, was not inhibited by the broad-spectrum caspase inhibitor zVAD-fmk or by expression of a dominant negative caspase 9 (9DN). However, zVAD-fmk was efficacious in inhibiting cell death triggered by an activating anti-Fas/CD95 antibody. In addition, bcl-XS does not possess the 5th and 6th {alpha}-helices (thought to be the membrane-spanning domains in bcl-2, bcl-XL, and bax) and, therefore, should not be able to form membrane channels, thus eliminating this possible mechanism of action. The finding that bcl-XS kills 3T3 cells without caspase activation, along with the absence of membrane spanning domains in bcl-XS, may, therefore, represent a novel cell death pathway for the pro-death bcl-2 family members.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
T. Braun, S. Dar, D. Vorobiov, L. Lindenboim, N. Dascal, and R. Stein
Expression of Bcl-xS in Xenopus Oocytes Induces BH3-Dependent and Caspase-Dependent Cytochrome c Release and Apoptosis
Mol. Cancer Res., January 1, 2003; 1(3): 186 - 194.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. S. Fridman, J. Parsels, A. Rehemtulla, and J. Maybaum
Cytochrome c Depletion upon Expression of Bcl-XS
J. Biol. Chem., February 2, 2001; 276(6): 4205 - 4210.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-F. Sun, L.-Y. Yu, M. Saarma, T. Timmusk, and U. Arumae
Neuron-specific Bcl-2 Homology 3 Domain-only Splice Variant of Bak Is Anti-apoptotic in Neurons, but Pro-apoptotic in Non-neuronal Cells
J. Biol. Chem., May 4, 2001; 276(19): 16240 - 16247.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.